Is antimicrobial susceptibility testing necessary before first-line treatment for Helicobacter pylori infection? Meta-analysis of randomized controlled trials.
about
Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infectionManagement of Helicobacter pylori infection in Latin America: a Delphi technique-based consensusHelicobacter pylori Eradication Therapy: Current Availabilities.Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations.Current options for the treatment of Helicobacter pylori.Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection.Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of Helicobacter pylori Infection: Two Pilot Studies.Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance.Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection.Recent advances in Helicobacter pylori eradication.Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?Is there still a role for empiric first-line triple therapy using proton pump inhibitor, amoxicillin and clarithromycin for Helicobacter pylori infection in Singapore? Results of a time trend analysis.Helicobacter pylori Antimicrobial Susceptibility Testing-Guided Salvage Therapy in the USA: A Real Life Experience.Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance.Current Status of the Third-Line Helicobacter pylori Eradication.Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.Effectiveness of Helicobacter pylori eradication established on the basis of examination of antibiotic resistance of the bacteria.
P2860
Q26853010-257CC897-FCBB-47E7-853B-4959E1758D34Q34067951-993C0207-26E8-491C-8F1F-EE5898DEB191Q36148148-FA806059-F308-497D-92EC-C0CFC9ECE8C9Q38052634-E27DBE69-CAE6-4D24-8136-767184F7CFE5Q38075061-C7464B1B-3864-4D84-A8BC-53A3E8B8BAEBQ38238745-50C83632-CCE4-4EB5-A5D6-E8335D1105AEQ38238746-E59045DE-F3B4-40F7-AD0A-E0F284C7280FQ38621376-0C0158A3-7388-4671-AA84-B2E6440A913EQ40819420-86590FC6-4B8B-4716-A59E-17B6648F20B4Q41224420-DDCD76AC-7AD4-4A47-884F-51D4636356A0Q41511318-0FD131C6-8ADA-4D7F-B351-5D46CBA037F3Q42090635-A469A3AC-3EF4-4C71-950E-01ECBDCDEBA7Q42362197-05F5E859-C726-4382-B80C-E0856088C269Q46946382-D0CC0E95-E373-4665-88ED-681A3AC284FBQ47188106-7D9A8051-2AD5-4B1E-A023-B0B91A7DFCCAQ51064675-66CB9B70-943C-475A-BBFE-8BC923FFF5FAQ55056772-020F4B34-EADD-4B38-85ED-B73A684EB740Q55488297-7625C6E4-6873-494C-9277-41C0AC55090BQ55617245-474A48DA-93BC-4152-AAD1-D062F19877C9
P2860
Is antimicrobial susceptibility testing necessary before first-line treatment for Helicobacter pylori infection? Meta-analysis of randomized controlled trials.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Is antimicrobial susceptibilit ...... randomized controlled trials.
@ast
Is antimicrobial susceptibilit ...... randomized controlled trials.
@en
type
label
Is antimicrobial susceptibilit ...... randomized controlled trials.
@ast
Is antimicrobial susceptibilit ...... randomized controlled trials.
@en
prefLabel
Is antimicrobial susceptibilit ...... randomized controlled trials.
@ast
Is antimicrobial susceptibilit ...... randomized controlled trials.
@en
P2093
P1433
P1476
Is antimicrobial susceptibilit ...... randomized controlled trials.
@en
P2093
Guan Quanlin
Wang Donghai
Yang Lijuan
Yuan Wenzhen
P304
P356
10.2169/INTERNALMEDICINE.49.3031
P577
2010-06-15T00:00:00Z